Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ovarian Neoplasms

Free Subscription 15.07.2024 1 Am J Obstet Gynecol 1 BMC Cancer 1 Curr Treat Options Oncol 2 Gynecol Oncol 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Obstet Gynecol

1. MORO F, Pinto AP, Chiappa V, Testa AC, et al
   Prediction of non-resectability using the updated Predictive Index Value model assessed by imaging and surgery in tubo-ovarian cancer: a prospective multicenter ISAAC study.
   Am J Obstet Gynecol. 2024 Jul 3:S0002-9378(24)00740.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. RUBIO MJ, Manzano A, de Sande LM, Estevez-Garcia P, et al
   Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study.
   BMC Cancer. 2024;24:803.
   PubMed         Abstract available
   
   

   
   Curr Treat Options Oncol

3. GONZALEZ A, Nagel CI, Haight PJ
   Targeted Therapies in Low-Grade Serous Ovarian Cancers.
   Curr Treat Options Oncol. 2024;25:854-868.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

4. ANDRES S, Finch L, Iasonos A, Zhou Q, et al
   Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer.
   Gynecol Oncol. 2024;189:30-36.
   PubMed         Abstract available
   
   
5. MAHONEY DE, Mukherjee R, Thompson J
   Elucidating the influences of social determinants of health on perceived overall health among African American/Black and Hispanic ovarian cancer survivors using the NIH All of Us Research Program.
   Gynecol Oncol. 2024;189:24-29.
   PubMed         Abstract available
   
   

   
   PLoS One

6. ZHAO S, Wang L, Ouyang M, Xing S, et al
   Polyploid giant cancer cells induced by Docetaxel exhibit a senescence phenotype with the expression of stem cell markers in ovarian cancer cells.
   PLoS One. 2024;19:e0306969.
   PubMed         Abstract available
   
   
7. ANCHOORI RK, Tseng SH, Tsai HL, Palande V, et al
   Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer.
   PLoS One. 2024;19:e0305710.
   PubMed         Abstract available
   
   
8. MA MC, Lavi ES, Altwerger G, Lin ZP, et al
   Predictive modeling of gene mutations for the survival outcomes of epithelial ovarian cancer patients.
   PLoS One. 2024;19:e0305273.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.